By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rodin Therapeutics 

25 First Street #303

Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax: n/a



Company News
Rodin Nabs $27 Million to Carry HDAC Complex Compound into the Clinic 9/20/2017 1:57:12 PM
Rodin Advances Synaptic Resilience Strategy With $27 Million In Financing And Expands Board Of Directors 9/18/2017 6:28:34 AM
Sans Biogen (BIIB)'s $485 Million Buyout Option, Rodin Nabs $27 Million For Alzheimer's 9/18/2017 6:01:59 AM
Rodin Expands Leadership Team And Advisory Boards To Advance Novel, Selective HDAC Inhibitors Towards The Clinic 9/22/2016 11:09:53 AM
Rodin and Biogen (BIIB) Ink Possible Acquisition Deal for up to $485 Million 1/6/2016 6:08:41 AM
Rodin Therapeutics Appoints Samantha Singer To Board Of Directors 12/21/2015 1:23:09 PM
Rodin Therapeutics Appoints Adam J. Rosenberg As Chief Executive Officer 10/6/2015 10:29:32 AM
Johnson & Johnson (JNJ) Shows Off Deals With Six Boston Biotech Firms— Padlock Therapeutics, Energesis Pharmaceuticals, Navitor Pharmaceuticals, Ascelegen Therapeutics, Minerva Neurosciences, Inc. (NERV), And Rodin Therapeutics 6/19/2014 7:05:05 AM
Cambridge-Based Biotech Rodin Therapeutics Snags $12.9 Million Series A Financing 5/29/2014 7:40:29 AM
Atlas Startup, Rodin Therapeutics, Hopes to Rewire Neurons to Improve Memory 8/14/2013 7:07:53 AM